{"id":"meriva","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT03864783","NCT02782949","NCT01330810","NCT01948661","NCT01740323","NCT05349032","NCT03289832","NCT01859858","NCT02909686","NCT02017353","NCT04109742","NCT03584724","NCT04705220","NCT03621865","NCT02543931","NCT06423586"],"aliases":["turmeric, enhanced bioavailability"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Meriva","companyId":"university-of-arizona","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"University of Arizona","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Meriva","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03864783","phase":"NA","title":"The Effect of Curcumin on Liver Fat Content in Obese Subjects","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","isPivotal":false,"enrollment":39,"indication":"Non-Alcoholic Fatty Liver Disease, Insulin Resistance","completionDate":"2020-12-16"},{"nctId":"NCT02782949","phase":"Phase 2","title":"Randomized, Double-Blind, Placebo-Controlled Trial of Meriva® (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","isPivotal":false,"enrollment":50,"indication":"Chronic Atrophic Gastritis, Gastric Carcinoma","completionDate":"2026-04-01"},{"nctId":"NCT01330810","phase":"Phase 1","title":"Crossover, Multiple Dose Pharmacokinetics of Two Curcumin Formulations in Healthy Volunteers","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","isPivotal":false,"enrollment":12,"indication":"Comparative Multidose Pharmacokinetics","completionDate":"2012-04"},{"nctId":"NCT01948661","phase":"NA","title":"Randomized Window of Opportunity Trial of Anthocyanin Extract and Phospholipid Curcumin in Subjects With Colorectal Adenoma","status":"COMPLETED","sponsor":"Ente Ospedaliero Ospedali Galliera","isPivotal":false,"enrollment":45,"indication":"Colorectal Adenoma, Risk Reduction","completionDate":"2022-06-20"},{"nctId":"NCT01740323","phase":"Phase 2","title":"Meriva for Treatment-induced Inflammation and Fatigue in Women With Breast Cancer","status":"COMPLETED","sponsor":"Andrew H Miller","isPivotal":false,"enrollment":30,"indication":"Breast Cancer","completionDate":"2018-07-27"},{"nctId":"NCT05349032","phase":"NA","title":"Assessing the Bioavailability of Leading Phytonutrient Products","status":"UNKNOWN","sponsor":"Epiceutical Labs","isPivotal":false,"enrollment":15,"indication":"Inflammation","completionDate":"2022-06"},{"nctId":"NCT03289832","phase":"NA","title":"Effect of Orally Delivered Phytochemicals, Alone, and in Combination, on Aging and Inflammation-Related Effects in the Skin","status":"COMPLETED","sponsor":"Johns Hopkins University","isPivotal":false,"enrollment":25,"indication":"Healthy Adults","completionDate":"2019-10-23"},{"nctId":"NCT01859858","phase":"Phase 1","title":"A Prospective Evaluation of the Effect of Curcumin on Dose-limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer Patients","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","isPivotal":false,"enrollment":23,"indication":"Advanced Colorectal Cancer","completionDate":"2016-10-05"},{"nctId":"NCT02909686","phase":"NA","title":"Effects of Botanical Microglia Modulators in Gulf War Illness","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","isPivotal":false,"enrollment":36,"indication":"Gulf War Illness","completionDate":"2022-09"},{"nctId":"NCT02017353","phase":"Phase 2","title":"Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma","status":"COMPLETED","sponsor":"University Hospital, Gasthuisberg","isPivotal":false,"enrollment":7,"indication":"Endometrial Carcinoma","completionDate":"2016-10"},{"nctId":"NCT04109742","phase":"Phase 2","title":"Curcumin for Pediatric Nonalcoholic Fatty Liver Disease: A Pilot Randomized Controlled Trial","status":"WITHDRAWN","sponsor":"Columbia University","isPivotal":false,"enrollment":0,"indication":"NAFLD - Nonalcoholic Fatty Liver Disease, NASH - Nonalcoholic Steatohepatitis","completionDate":"2020-04-22"},{"nctId":"NCT03584724","phase":"EARLY/Phase 1","title":"Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis: a Multicenter Randomized, Placebo Controlled, Double-blind Clinical Study","status":"COMPLETED","sponsor":"Eye Pharma","isPivotal":false,"enrollment":49,"indication":"Uveitis","completionDate":"2020-12-30"},{"nctId":"NCT04705220","phase":"NA","title":"Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome","status":"COMPLETED","sponsor":"Indena S.p.A","isPivotal":false,"enrollment":85,"indication":"Mild Cognitive Impairment","completionDate":"2025-12-19"},{"nctId":"NCT03621865","phase":"NA","title":"A Comparative Pharmacokinetic Study in Healthy Volunteers to Evaluate the Ability of TURMIPURE GOLD Formulation to Enhance the Bioavailability of Curcuminoids","status":"COMPLETED","sponsor":"Givaudan France Naturals","isPivotal":false,"enrollment":30,"indication":"Healthy","completionDate":"2018-10-26"},{"nctId":"NCT02543931","phase":"Phase 1","title":"Phase Ib Randomized, Double-Blind, Placebo-Controlled Study of Meriva in Rheumatoid Arthritis","status":"TERMINATED","sponsor":"University of Arizona","isPivotal":false,"enrollment":3,"indication":"Rheumatoid Arthritis","completionDate":"2017-09"},{"nctId":"NCT06423586","phase":"NA","title":"Positive Effect of Lecithin-based Delivery Form of Curcuma and Boswellia Extracts on Post-acute COVID-19 Irritable Bowel Syndrome. Two Cohorts of an Open-label Study.","status":"COMPLETED","sponsor":"Azienda di Servizi alla Persona di Pavia","isPivotal":false,"enrollment":44,"indication":"Post-Acute COVID-19 Syndrome, Irritable Bowel Syndrome","completionDate":"2022-06-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}